KMAP BULLETIN: Preferred Drug List Update

Date: 07/06/23

There is a Preferred Drug List (PDL) update effective July 1, 2023. Reference the Preferred Drug List page on the Kansas Department of Health and Environment (KDHE) website.

The following medications are now non-preferred and a PDL Prior Authorization (PA) is required:
    • TBO-Filgrastim (Granix®) Syringe, Vial
    • Sildenafil (Liqrev®) Oral Suspension
    • Daridorexant (Quviviq®) Tablet

The following medications are now preferred and a PDL PA is no longer required:
    • Semaglutide (Ozempic®) Pen
    • Lemborexant (Dayvigo®) Tablet
    • Suvorexant (Belsomra®) Tablet

Note: The effective date of the policy is July 1, 2023. The implementation of State policy by the KanCare Managed Care Organizations (MCOs) may vary from the date noted in the Kansas Medical Assistance Program (KMAP) bulletins. The KanCare Open Claims Resolution Log on the KMAP Bulletins page documents the MCO system status for policy implementation and any associated reprocessing completion dates once the policy is implemented.